The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma
Condition(s):High-Risk Localized Soft Tissue SarcomaLast Updated:March 17, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):High-Risk Localized Soft Tissue SarcomaLast Updated:March 17, 2023Recruiting
Condition(s):Soft Tissue SarcomaLast Updated:February 27, 2023Recruiting
Condition(s):Soft Tissue Sarcoma of the ExtremityLast Updated:December 16, 2022Recruiting
Condition(s):Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in AdultsLast Updated:November 16, 2021Active, not recruiting
Condition(s):Soft Tissue SarcomaLast Updated:November 2, 2022Recruiting
Condition(s):Unresectable Localized Soft Tissue SarcomaLast Updated:September 18, 2018Recruiting
Condition(s):Soft Tissue SarcomaLast Updated:November 8, 2022Completed
Condition(s):Soft Tissue Sarcoma; Desmoid; AbdominalLast Updated:January 19, 2023Recruiting
Condition(s):Childhood Malignant Fibrous Histiocytoma of Bone; SarcomaLast Updated:August 12, 2013Unknown status
Condition(s):FNCLCC Sarcoma Grade 2; FNCLCC Sarcoma Grade 3; Resectable Leiomyosarcoma; Resectable Liposarcoma; Resectable Soft Tissue Sarcoma; Resectable Undifferentiated Pleomorphic Sarcoma; Soft Tissue Sarcoma of the Trunk and Extremities; Stage I Soft Tissue Sarcoma AJCC v7; Stage II Soft Tissue Sarcoma AJCC v7Last Updated:March 8, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.